Xbrane AB (publ) today announces that the company's CFO, Anette Lindqvist, has announced her intention to retire and will leave her position during the spring of 2025.

MAR

Xbrane Biopharma AB today announces that Chief Financial Officer & Head of IR Anette Lindqvist has informed CEO Marin Åmark of her intention to scale back her operational work and thereby leave her position as CFO during the spring of 2025. Anette has been CFO for Xbrane since 2021 and will remain in her role until a replacement is secured. The recruitment process for a new CFO will begin immediately.

"I would like to thank Anette for her work in recent years and wish her the best of luck with her plans to have more time for other things. The recruitment process for a new CFO will begin immediately and I feel confident that Anette, together with her competent employees, will guarantee a smooth handover process," says Martin Åmark, CEO.

"Xbrane is a fantastic company with very talented and knowledgeable colleagues with whom it has been a pleasure to work and whom I will miss a lot, while I look forward to having more time for other interests," says Anette Lindqvist CFO.

Datum 2024-11-26, kl 17:20
Källa MFN
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet